Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01403441 · ClinicalTrials.gov registry record · NA
Radiosurgical Neuromodulation for Refractory Depression
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01403441: Clinical Trial NA study, sponsored by Stanford University.
NCT01403441 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01403441, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is designed to evaluate the safety and effectiveness of an investigational procedure for treating people with treatment resistant bipolar depression (TRD). Precise dose delivery of radiation to the predetermined targets in the brain will be accomplished with known Cyberknife stereotactic radiosurgery methods. This technology is considered to be noninvasive (does not physically invade your body). We will be studying if the Cyberknife influences the sensitivity of certain nerves of your brain. Although many clinical treatments for psychiatric conditions have been done using stereotactic radiosurgery, the present study is experimental, because we are seeking to use more moderate doses of radiation that are intended not to destroy any brain cells, but to normalize or modulate their function.
Primary Outcome
An event that required hospitalization due to an unanticipated worsening of the subjects bipolar disorder.
Interventions
- DEVICE Radiosurgical Neuromodulation using the Cyberknife
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-01 |
| Phase | NA |
Why NCT01403441 stopped before completion
NCT01403441 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Radiosurgical Neuromodulation using the Cyberknife is the first listed.
NCT01403441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01403441 about?
NCT01403441 is a clinical study titled "Radiosurgical Neuromodulation for Refractory Depression". This study is designed to evaluate the safety and effectiveness of an investigational procedure for treating people with treatment resistant bipolar depression (TRD). Precise dose delivery of radiation to the predetermined targets in the brain will be accomplished with known Cyberknife stereotactic ...
What is the current status of trial NCT01403441?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2010-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01403441?
The interventions under investigation include: Radiosurgical Neuromodulation using the Cyberknife (DEVICE).
Who is sponsoring clinical trial NCT01403441?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01403441's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia